Literature DB >> 23782236

Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.

Patrick Masson1, Sofya Lushchekina, Lawrence M Schopfer, Oksana Lockridge.   

Abstract

CSP (cresyl saligenin phosphate) is an irreversible inhibitor of human BChE (butyrylcholinesterase) that has been involved in the aerotoxic syndrome. Inhibition under pseudo-first-order conditions is biphasic, reflecting a slow equilibrium between two enzyme states E and E'. The elementary constants for CSP inhibition of wild-type BChE and D70G mutant were determined by studying the dependence of inhibition kinetics on viscosity and osmotic pressure. Glycerol and sucrose were used as viscosogens. Phosphorylation by CSP is sensitive to viscosity and is thus strongly diffusion-controlled (kon≈10⁸ M⁻¹·min⁻¹). Bimolecular rate constants (ki) are about equal to kon values, making CSP one of the fastest inhibitors of BChE. Sucrose caused osmotic stress because it is excluded from the active-site gorge. This depleted the active-site gorge of water. Osmotic activation volumes, determined from the dependence of ki on osmotic pressure, showed that water in the gorge of the D70G mutant is more easily depleted than that in wild-type BChE. This demonstrates the importance of the peripheral site residue Asp⁷⁰ in controlling the active-site gorge hydration. MD simulations provided new evidence for differences in the motion of water within the gorge of wild-type and D70G enzymes. The effect of viscosogens/osmolytes provided information on the slow equilibrium E⇌E', indicating that alteration in hydration of a key catalytic residue shifts the equilibrium towards E'. MD simulations showed that glycerol molecules that substitute for water molecules in the enzyme active-site gorge induce a conformational change in the catalytic triad residue His⁴³⁸, leading to the less reactive form E'.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23782236     DOI: 10.1042/BJ20130389

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Molecular modeling evidence for His438 flip in the mechanism of butyrylcholinesterase hysteretic behavior.

Authors:  Sofya V Lushchekina; Alexander V Nemukhin; Sergei D Varfolomeev; Patrick Masson
Journal:  J Mol Neurosci       Date:  2013-12-06       Impact factor: 3.444

2.  Characterization of butyrylcholinesterase in bovine serum.

Authors:  Alicia J Dafferner; Sofya Lushchekina; Patrick Masson; Gaoping Xiao; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2017-02-08       Impact factor: 5.192

3.  Kinetic Mechanisms of Fast Glutamate Sensing by Fluorescent Protein Probes.

Authors:  Catherine Coates; Silke Kerruth; Nordine Helassa; Katalin Török
Journal:  Biophys J       Date:  2019-11-14       Impact factor: 4.033

4.  Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase.

Authors:  N P Boltneva; G F Makhaeva; N V Kovaleva; S V Lushchekina; Ya V Burgart; E V Shchegol'kov; V I Saloutin; O N Chupakhin
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

5.  Probing the Catalytic Mechanism of Copper Amine Oxidase from Arthrobacter globiformis with Halide Ions.

Authors:  Takeshi Murakawa; Akio Hamaguchi; Shota Nakanishi; Misumi Kataoka; Tadashi Nakai; Yoshiaki Kawano; Hiroshi Yamaguchi; Hideyuki Hayashi; Katsuyuki Tanizawa; Toshihide Okajima
Journal:  J Biol Chem       Date:  2015-08-11       Impact factor: 5.157

6.  Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.

Authors:  Sergey O Bachurin; Elena F Shevtsova; Galina F Makhaeva; Vladimir V Grigoriev; Natalia P Boltneva; Nadezhda V Kovaleva; Sofya V Lushchekina; Pavel N Shevtsov; Margarita E Neganova; Olga M Redkozubova; Elena V Bovina; Alexey V Gabrelyan; Vladimir P Fisenko; Vladimir B Sokolov; Alexey Yu Aksinenko; Valentina Echeverria; George E Barreto; Gjumrakch Aliev
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

7.  Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases.

Authors:  Sergey O Bachurin; Galina F Makhaeva; Elena F Shevtsova; Natalia P Boltneva; Nadezhda V Kovaleva; Sofya V Lushchekina; Elena V Rudakova; Ludmila G Dubova; Daria V Vinogradova; Vladimir B Sokolov; Alexey Yu Aksinenko; Vladimir P Fisenko; Rudy J Richardson; Gjumrakch Aliev
Journal:  Sci Rep       Date:  2019-03-19       Impact factor: 4.379

8.  Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease.

Authors:  Galina F Makhaeva; Sofya V Lushchekina; Natalia P Boltneva; Vladimir B Sokolov; Vladimir V Grigoriev; Olga G Serebryakova; Ekaterina A Vikhareva; Alexey Yu Aksinenko; George E Barreto; Gjumrakch Aliev; Sergey O Bachurin
Journal:  Sci Rep       Date:  2015-08-18       Impact factor: 4.379

9.  Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.

Authors:  Herve Delacour; Sofya Lushchekina; Isabelle Mabboux; Aurore Bousquet; Franck Ceppa; Lawrence M Schopfer; Oksana Lockridge; Patrick Masson
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

10.  Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase.

Authors:  Irina V Zueva; Sofya V Lushchekina; Patrick Masson
Journal:  Biosci Rep       Date:  2018-06-29       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.